Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$19.39 - $28.9 $530,103 - $790,097
-27,339 Reduced 8.45%
296,368 $8 Million
Q1 2023

May 05, 2023

SELL
$12.71 - $21.17 $29,932 - $49,855
-2,355 Reduced 0.72%
323,707 $6.37 Million
Q2 2021

Jul 23, 2021

SELL
$29.4 - $35.96 $294,000 - $359,600
-10,000 Reduced 2.98%
326,062 $10.3 Million
Q1 2021

May 03, 2021

SELL
$28.09 - $34.02 $477,782 - $578,646
-17,009 Reduced 4.82%
336,062 $10.7 Million
Q4 2020

Feb 03, 2021

SELL
$20.44 - $30.88 $684,188 - $1.03 Million
-33,473 Reduced 8.66%
353,071 $10.6 Million
Q1 2020

Apr 30, 2020

BUY
$8.36 - $22.67 $20,423 - $55,382
2,443 Added 0.64%
386,544 $4.62 Million
Q2 2019

Aug 13, 2019

BUY
$15.13 - $20.34 $5.81 Million - $7.81 Million
384,101 New
384,101 $7.81 Million

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $568M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Meridian Investment Counsel Inc. Portfolio

Follow Meridian Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Meridian Investment Counsel Inc. with notifications on news.